ADVERSE IMPACTS OF SEVERE ASCVD: Is PCSK9 Inhibition the Key to Improve Patient Outcomes?

Recorded live at the MEDX Regional CME Conference held in Irving, TX on September 29, 2017

Jointly provided by Boston University School of Medicine and Rockpointe.